(UPDATED) Swift initiation of rhythm-control therapy in patients with recently diagnosed atrial fibrillation in the setting of other cardiovascular conditions reduced the risk of CV events as compared ...
Most patients received flecainide, dronedarone, or amiodarone. At baseline, sinus rhythms were recorded more often in patients in the early rhythm control vs standard care group. Catheter ablation was ...
Sophia Antipolis, 27 March 2023: Patients with atrial fibrillation (AF) benefit from early rhythm control therapy. It reduces cardiovascular deaths, strokes, and other adverse outcomes by 20% compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results